pharma news, views and analysis

in News

Novartis builds case for iptacopan as oral rival to PNH injectables

December 8, 2022

Novartis builds case for iptacopan as oral rival to PNH injectables

https://pharmaphorum.com/news/novartis-builds-case-for-iptacopan-as-oral-rival-to-pnh-injectables/

Novartis has a second positive phase 3 trial in the bag for its targeted factor B inhibitor iptacopan,

in News

GSK trumpets Jemperli vs Keytruda data in first-line NSCLC

December 8, 2022

GSK trumpets Jemperli vs Keytruda data in first-line NSCLC

https://pharmaphorum.com/news/gsk-trumpets-jemperli-vs-keytruda-data-in-first-line-nsclc/

GSK says its PD-1 inhibitor Jemperli compared favourably with Merck & Co’s Keytruda in a head-to-head trial in

Latest News

Investigation launched into alleged animal welfare violations at Neuralink

Elon Musk’s brain computer interface (BCI) company Neuralink is being investigated by law enforcement authorities in the US

Investigation launched into alleged animal welfare violations at Neuralink

https://pharmaphorum.com/news/investigation-launched-into-alleged-animal-welfare-violations-at-neuralink/

Little Summit Therapeutics spends big bucks to rebuild pipeline

$500 million upfront and a total deal value of up to $5 billion sounds like a deal made

Little Summit Therapeutics spends big bucks to rebuild pipeline

https://pharmaphorum.com/news/little-summit-therapeutics-spends-big-bucks-to-rebuild-pipeline/

1200px-Human_Natural_Killer_Cell_(29120480442)

New Nkarta data backs up natural killer approach to cancer treatment

Harnessing the power of natural killer (NK) cells to attack cancer is as-yet an unproven strategy in oncology

New Nkarta data backs up natural killer approach to cancer treatment

https://pharmaphorum.com/news/new-data-backs-up-nkarta-natural-killer-approach-to-cancer/

See all

Views & Analysis

How eligible patient numbers affect price of rare disease drugs in France

Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Life Sciences Practice

How eligible patient numbers affect price of rare disease drugs in France

https://pharmaphorum.com/views-and-analysis/how-eligible-patient-numbers-affect-price-of-rare-disease-drugs-in-france/

Improving trial predictability: leveraging AI-powered analytics to guide trial design, strategy, and operations

Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and

Improving trial predictability: leveraging AI-powered analytics to guide trial design, strategy, and operations

https://pharmaphorum.com/views-and-analysis/improving-trial-predictability-leveraging-ai-powered-analytics/

Increasing sustainability in pharma requires an industry-wide effort

With COP27 concluding in November, Ben Hargreaves takes a look at what efforts pharma companies are making to

Increasing sustainability in pharma requires an industry-wide effort

https://pharmaphorum.com/views-and-analysis/increasing-sustainability-in-pharma-requires-an-industry-wide-effort/

See all

Debates & Insights

Synthetic control arms in clinical trials: Making it happen

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges

Synthetic control arms in clinical trials: Making it happen

https://pharmaphorum.com/webinars/synthetic-control-arms-in-clinical-trials-making-it-happen/

Customer engagement and pharma’s field force future

How healthcare professionals (HCPs) prefer to engage with pharma companies has been changing for some time, and COVID’s

Customer engagement and pharma’s field force future

https://pharmaphorum.com/webinars/axtria-customer-engagement-pharmas-field-force-future-digital-transformation/

SAVANA_webinar_holding_slide-23.03.21-1200x675

AI, big data and deep real-world evidence – the challenges and opportunities

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights

AI, big data and deep real-world evidence – the challenges and opportunities

https://pharmaphorum.com/webinars/ai-big-data-real-world-evidence-savana/

See all

Partner Content

6th Annual 3D Cell Culture Conference

www.3d-cellculture.com/PharmaphorumWL Exploring the implementation of complex in-vitro models for drug development Join us in February 2023, as SAE

6th Annual 3D Cell Culture Conference

https://pharmaphorum.com/partner-content/6th-annual-3d-cell-culture-conference/

Role of KOL influence

Why KOL Influence Drives KOL Engagement You have in front of you a syndicated KOL database of gargantuan

Role of KOL influence

https://pharmaphorum.com/partner-content/role-of-kol-influence/

6 Ways to Prioritize the Patient Voice in Patient Journey Research

6 ways to bring the patient voice to the forefront

6 Ways to Prioritize the Patient Voice in Patient Journey Research

https://pharmaphorum.com/partner-content/6-ways-to-prioritize-the-patient-voice-in-patient-journey-research/

See all

Trending

Login